Snider RM - Search Results

1

CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor.

McLean S, Snider RM, Desai MC, Rosen T, Bryce DK, Longo KP, Schmidt AW, Heym J. McLean S, et al. Among authors: snider rm. Regul Pept. 1993 Jul 2;46(1-2):329-31. doi: 10.1016/0167-0115(93)90075-j. Regul Pept. 1993. PMID: 8210497 No abstract available.

2

A potent nonpeptide antagonist of the substance P (NK1) receptor.

Snider RM, Constantine JW, Lowe JA 3rd, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW, et al. Snider RM, et al. Science. 1991 Jan 25;251(4992):435-7. doi: 10.1126/science.1703323. Science. 1991. PMID: 1703323

3

Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.

Snider RM, Longo KP, Drozda SE, Lowe JA 3rd, Leeman SE. Snider RM, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10042-4. doi: 10.1073/pnas.88.22.10042. Proc Natl Acad Sci U S A. 1991. PMID: 1719543 Free PMC article.

4

Discovery of CP-96,345 and its characterization in disease models involving substance P.

Lowe JA 3rd, Drozda SE, Snider RM, Longo KP, Zorn SH, Jackson ER, Morrone J, McLean S, Bryce DK, Bordner J, et al. Lowe JA 3rd, et al. Among authors: snider rm. Regul Pept. 1993 Jul 2;46(1-2):20-3. doi: 10.1016/0167-0115(93)90006-t. Regul Pept. 1993. PMID: 7692490 Review.

5

Differential SAR of quinuclidine SP antagonists between rat and human-type receptors.

Snider RM, Longo KP, Zorn SH, Morrone J, Jackson ER, Nagahisa A, Kanai Y, Suga O, Nakagaki M, Drozda SE, et al. Snider RM, et al. Regul Pept. 1993 Jul 2;46(1-2):290-2. doi: 10.1016/0167-0115(93)90063-e. Regul Pept. 1993. PMID: 7692519 No abstract available.

6

Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.

McLean S, Ganong A, Seymour PA, Snider RM, Desai MC, Rosen T, Bryce DK, Longo KP, Reynolds LS, Robinson G, et al. McLean S, et al. Among authors: snider rm. J Pharmacol Exp Ther. 1993 Oct;267(1):472-9. J Pharmacol Exp Ther. 1993. PMID: 7693914

7

Discovery of a potent substance P antagonist: recognition of the key molecular determinant.

Desai MC, Lefkowitz SL, Thadeio PF, Longo KP, Snider RM. Desai MC, et al. Among authors: snider rm. J Med Chem. 1992 Dec 25;35(26):4911-3. doi: 10.1021/jm00104a018. J Med Chem. 1992. PMID: 1282570 No abstract available.

8

The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst.

Lowe JA 3rd, Drozda SE, Snider RM, Longo KP, Zorn SH, Morrone J, Jackson ER, McLean S, Bryce DK, Bordner J, et al. Lowe JA 3rd, et al. Among authors: snider rm. J Med Chem. 1992 Jul 10;35(14):2591-600. doi: 10.1021/jm00092a009. J Med Chem. 1992. PMID: 1378901

9

Aza-tricyclic substance P antagonists.

Lowe JA 3rd, Drozda SE, McLean S, Bryce DK, Crawford RT, Snider RM, Longo KP, Nagahisa A, Tsuchiya M. Lowe JA 3rd, et al. Among authors: snider rm. J Med Chem. 1994 Sep 2;37(18):2831-40. doi: 10.1021/jm00044a002. J Med Chem. 1994. PMID: 7520943

10

A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.

Piedimonte G, Bertrand C, Geppetti P, Snider RM, Desai MC, Nadel JA. Piedimonte G, et al. Among authors: snider rm. J Pharmacol Exp Ther. 1993 Jul;266(1):270-3. J Pharmacol Exp Ther. 1993. PMID: 7687291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters